Synapse - Craig Moskowitz

Results (407)

Safety and early data from a phase II trial of pembrolizumab (PEM) and entinostat (ENT) in relapsed and refractory (R/R) Hodgkin lymphoma (Hl) and follicular lymphoma (FL)

Meeting Abstract

Sermer, D.; Vardhana, S.; Batlevi, C.; Hamilton, A.; Moskowitz, A.; Caron, P.; Moskowitz, C.; Matasar, M.; Biggar, E.; Leung, E.; more...
Hematological Oncology (2019)

Fulltext@MSK | Save

Active surveillance for nodular lymphocyte-predominant Hodgkin lymphoma

Journal Article

Borchmann, S.; Joffe, E.; Moskowitz, C. H.; Zelenetz, A. D.; Noy, A.; Portlock, C. S.; Gerecitano, J. F.; Batlevi, C. L.; Caron, P. C.; Drullinsky, P.; more...
Blood (2019)

Fulltext@MSK | Save

Patterns of survival in patients with recurrent mantle cell lymphoma in the modern era: Progressive shortening in response duration and survival after each relapse

Journal Article

Kumar, A.; Sha, F.; Toure, A.; Dogan, A.; Ni, A.; Batlevi, C. L.; Palomba, M. L. M.; Portlock, C.; Straus, D. J.; Noy, A.; more...
Blood Cancer Journal (2019)

Fulltext@MSK | Save

Clinical presentation determines selection of patients for initial observation in mantle cell lymphoma

Journal Article

Kumar, A.; Ying, Z.; Alperovich, A.; Dogan, A.; Hamlin, P.; Moskowitz, C.; Pichardo, J.; Portlock, C.; Sha, F.; Zelenetz, A. D.; more...
Haematologica (2019)

Fulltext@MSK | Save

Long-term follow-up of SWOG S0816: Response-adapted therapy for stage III/IV Hodgkin lymphoma demonstrates limitations of PET-adapted approach

Meeting Abstract

Stephens, D. M.; Li, H.; Schoder, H.; Straus, D. J.; Moskowitz, C. H.; Leblanc, M. L.; Rimsza, L. M.; Bartlett, N. L.; Evens, A. M.; LaCasce, A. S.; more...
Blood (2018)

Fulltext@MSK | Save

Initial results of a phase II study of sequential chemotherapy and lenalidomide followed by rituximab and lenalidomide maintenance for untreated mantle cell lymphoma

Meeting Abstract

Kumar, A.; Zelenetz, A. D.; Batlevi, C. L.; Caron, P.; Dogan, A.; Drullinsky, P.; Gerecitano, J.; Hamilton, A.; Hamlin, P. A.; Laraque, L.; more...
Blood (2018)

Fulltext@MSK | Save

Highlights in lymphoma from the 2017 American Society of Hematology Meeting: Commentary

Journal Article

Moskowitz, C. H.
Clinical Advances in Hematology & Oncology (2018)

Fulltext@MSK | Save

Phase I/II clinical trial of ibrutinib and buparlisib in relapsed/refractory diffuse large B-cell lymphoma, mantle cell lymphoma, and follicular lymphoma

Meeting Abstract

Batlevi, C. L.; De Frank, S.; Stewart, C.; Hamlin, P. A.; Matasar, M. J.; Gerecitano, J. F.; Moskowitz, A. J.; Hamilton, A. M.; Zelenetz, A. D.; Drullinsky, P.; more...
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

Outcomes of relapsed and refractory primary mediastinal (thymic) large B cell lymphoma treated with second-line therapy and intent to transplant

Journal Article

Vardhana, S.; Hamlin, P. A.; Yang, J.; Zelenetz, A.; Sauter, C. S.; Matasar, M. J.; Ni, A.; Yahalom, J.; Moskowitz, C. H.
Biology of Blood and Marrow Transplantation (2018)

Fulltext@MSK | Save

CALGB 50604: Risk-adapted treatment of nonbulky early-stage Hodgkin lymphoma based on interim PET

Journal Article

Straus, D. J.; Jung, S. H.; Pitcher, B.; Kostakoglu, L.; Grecula, J. C.; Hsi, E. D.; Schöder, H.; Popplewell, L. L.; Chang, J. E.; Moskowitz, C. H.; more...
Blood (2018)

Fulltext@MSK | Save